(CANDLE-B) Candles Scandinavia Series - Ratings and Ratios
Scented Candles, Plant-Based Wax, Rapeseed Oil
CANDLE-B EPS (Earnings per Share)
CANDLE-B Revenue
Description: CANDLE-B Candles Scandinavia Series
Candles Scandinavia AB Series B is a Swedish company that specializes in manufacturing and selling scented candles made from plant-based wax derived from rapeseed oil. The company distributes its products under various private labels, including well-known brands like Yankee Candle and WoodWick, as well as its own brands. With its headquarters in Örebro, Sweden, the company was incorporated in 2009.
From a business perspective, Candles Scandinavia AB has a diversified revenue stream through its multiple private label partnerships, which can help mitigate risks associated with relying on a single brand. To further analyze the companys performance, key performance indicators (KPIs) such as revenue growth rate, gross margin, and operating margin can be examined. For instance, a high gross margin could indicate the companys ability to maintain a competitive pricing strategy while ensuring profitability.
Given the companys classification under the GICS Sub Industry: Personal Care Products, its essential to consider the broader industry trends. The home fragrance market is a growing segment, driven by increasing consumer demand for premium and sustainable products. As a manufacturer of eco-friendly scented candles, Candles Scandinavia AB is well-positioned to capitalize on this trend. To gauge the companys competitiveness, metrics such as market share, customer acquisition costs, and product innovation pipeline can be evaluated.
From a valuation perspective, the companys market capitalization stands at 244.83M SEK, with a forward P/E ratio of 158.73, indicating potentially high growth expectations. The return on equity (RoE) is currently negative at -21.24, suggesting that the company may be facing challenges in generating profits. To better understand the companys financial health, additional KPIs such as debt-to-equity ratio, interest coverage ratio, and cash flow conversion rate can be analyzed.
CANDLE-B Stock Overview
| Market Cap in USD | 38m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
CANDLE-B Stock Ratings
| Growth Rating | -12.9% |
| Fundamental | 41.8% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 62.0% |
| Analyst Rating | - |
CANDLE-B Dividends
Currently no dividends paidCANDLE-B Growth Ratios
| Growth Correlation 3m | 83.7% |
| Growth Correlation 12m | 36.5% |
| Growth Correlation 5y | -83.2% |
| CAGR 5y | -12.66% |
| CAGR/Max DD 5y | -0.15 |
| Sharpe Ratio 12m | -0.06 |
| Alpha | 99.63 |
| Beta | -0.608 |
| Volatility | 42.80% |
| Current Volume | 0.1k |
| Average Volume 20d | 8.3k |
| Stop Loss | 37.7 (-5.3%) |
| Signal | -4.26 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-6.37m TTM) > 0 and > 6% of Revenue (6% = 10.7m TTM) |
| FCFTA -0.01 (>2.0%) and ΔFCFTA -12.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.23% (prev 34.13%; Δ -15.91pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.01 (>3.0%) and CFO -2.02m > Net Income -6.37m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.86 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (8.65m) change vs 12m ago -0.01% (target <= -2.0% for YES) |
| Gross Margin 18.25% (prev -4.23%; Δ 22.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 126.0% (prev 159.6%; Δ -33.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -2.66 (EBITDA TTM -7.69m / Interest Expense TTM 4.13m) >= 6 (WARN >= 3) |
Altman Z'' 0.47
| (A) 0.19 = (Total Current Assets 70.8m - Total Current Liabilities 38.2m) / Total Assets 171.8m |
| (B) -0.08 = Retained Earnings (Balance) -13.8m / Total Assets 171.8m |
| (C) -0.08 = EBIT TTM -11.0m / Avg Total Assets 142.0m |
| (D) 0.01 = Book Value of Equity 865.1k / Total Liabilities 93.2m |
| Total Rating: 0.47 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 41.82
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield -0.47% = -0.23 |
| 3. FCF Margin -1.13% = -0.42 |
| 4. Debt/Equity 0.87 = 2.14 |
| 5. Debt/Ebitda -8.84 = -2.50 |
| 6. ROIC - WACC data missing |
| 7. RoE -8.01% = -1.33 |
| 8. Rev. Trend -14.57% = -0.73 |
| 9. Rev. CAGR 0.45% = 0.06 |
| 10. EPS Trend -26.08% = -0.65 |
| 11. EPS CAGR -56.29% = -2.50 |
What is the price of CANDLE-B shares?
Over the past week, the price has changed by -3.40%, over one month by -0.50%, over three months by +68.64% and over the past year by +89.52%.
Is Candles Scandinavia Series a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CANDLE-B is around 41.87 SEK . This means that CANDLE-B is currently overvalued and has a potential downside of 5.2%.
Is CANDLE-B a buy, sell or hold?
What are the forecasts/targets for the CANDLE-B price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28 | -29.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 44.7 | 12.3% |
CANDLE-B Fundamental Data Overview
Market Cap SEK = 364.3m (364.3m SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 353.0k SEK (Cash And Short Term Investments, last quarter)
P/E Forward = 158.7302
P/S = 2.0349
P/B = 4.58
Beta = 0.757
Revenue TTM = 179.0m SEK
EBIT TTM = -11.0m SEK
EBITDA TTM = -7.69m SEK
Long Term Debt = 55.0m SEK (from longTermDebt, last quarter)
Short Term Debt = 13.0m SEK (from shortTermDebt, last quarter)
Debt = 68.0m SEK (Calculated: Short Term 13.0m + Long Term 55.0m)
Net Debt = 67.6m SEK (from netDebt column, last quarter)
Enterprise Value = 432.0m SEK (364.3m + Debt 68.0m - CCE 353.0k)
Interest Coverage Ratio = -2.66 (Ebit TTM -11.0m / Interest Expense TTM 4.13m)
FCF Yield = -0.47% (FCF TTM -2.02m / Enterprise Value 432.0m)
FCF Margin = -1.13% (FCF TTM -2.02m / Revenue TTM 179.0m)
Net Margin = -3.56% (Net Income TTM -6.37m / Revenue TTM 179.0m)
Gross Margin = 18.25% ((Revenue TTM 179.0m - Cost of Revenue TTM 146.4m) / Revenue TTM)
Tobins Q-Ratio = 499.3 (set to none) (Enterprise Value 432.0m / Book Value Of Equity 865.1k)
Interest Expense / Debt = 2.71% (Interest Expense 1.85m / Debt 68.0m)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.86 (Total Current Assets 70.8m / Total Current Liabilities 38.2m)
Debt / Equity = 0.87 (Debt 68.0m / last Quarter total Stockholder Equity 78.6m)
Debt / EBITDA = -8.84 (Net Debt 67.6m / EBITDA -7.69m)
Debt / FCF = -33.59 (Debt 68.0m / FCF TTM -2.02m)
Total Stockholder Equity = 79.5m (last 4 quarters mean)
RoA = -3.71% (Net Income -6.37m, Total Assets 171.8m )
RoE = -8.01% (Net Income TTM -6.37m / Total Stockholder Equity 79.5m)
RoCE = -8.15% (Ebit -11.0m / (Equity 79.5m + L.T.Debt 55.0m))
RoIC = unknown (NOPAT none, Invested Capital 114.5m, Ebit -11.0m)
WACC = unknown (E(364.3m)/V(432.3m) * Re(3.77%)) + (D(68.0m)/V(432.3m) * Rd(2.71%) * (1-Tc(none)))
Shares Correlation 5-Years: 89.40 | Cagr: 2.53%
Discount Rate = 3.77% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -2.02m)
Revenue Correlation: -14.57 | Revenue CAGR: 0.45%
Rev Growth-of-Growth: 25.65
EPS Correlation: -26.08 | EPS CAGR: -56.29%
EPS Growth-of-Growth: 135.1